Researchers find potential new leukemia treatment with old antibiotic drug

November 14, 2011, University Health Network

Clinician-scientists in the Princess Margaret Cancer Program have found a promising approach to treating leukemia, using an old drug in a new way.

The proof-of-concept research published today in Cancer Cell describes how the Canadian team discovered that the antibiotic tigecycline targets and destroys leukemia by cutting off the cell's energy production.

"If you think of all the cells in the body as a , we've discovered that tigecycline can cause a in leukemia stem cells, while still keeping the lights on in all the healthy cells," says Dr. Aaron Schimmer, clinician-scientist at the Campbell Family Institute for in the Princess Margaret Cancer Program, University Health Network. He is also an associate professor in the departments of medicine, medical biophysics, and Institute of Medical Science at the University of Toronto (U of T).

To identify known drugs with previously unrecognized ability to kill and leukemia stem cells, the scientific team amassed a library of hundreds of known drugs to try, including tigecycline – an intravenous antibiotic normally used to treat skin and abdominal infections. A high-speed, pipette-handling robot tested varying doses of each drug to see if any affected leukemia cells.

"Technology made this discovery possible. In three days, we found which potential leukemia drugs might be hiding in plain sight," says Dr. Schimmer. "Sifting through every combination by hand would have taken months."

"We tested more than 500 existing drugs on leukemia. Of the handful that made an impact, tigecycline was the most potent and revealed novel insights into the biology of leukemia at a cellular level," says lead author, Marko Škrtić, an MD/PhD student in the Faculty of Medicine at U of T, completing his PhD studies in Dr. Schimmer's lab.

The Canadian team demonstrated that leukemia cells have unique energy requirements and it is possible to selectively shut down this in leukemia cells by blocking protein synthesis in the mitochondria.

By looking for new treatments in approved drugs, cancer researchers may be able to rapidly test these new strategies in patients, says Dr. Schimmer, who is now beginning multi-centre clinical trials with tigecycline as a treatment for leukemia.

Explore further: Clinical importance of leukemia stem cells validated

More information: DOI:10.1016/j.ccr.2011.10.015

Related Stories

Clinical importance of leukemia stem cells validated

August 28, 2011
Cancer scientists have long debated whether all cells within a tumour are equal or whether some cancer cells are more potent - a question that has been highly investigated in experimental models in the last decade. Research ...

Key to fighting drug-resistant leukemia found

May 18, 2011
Doctors who treat children with the most common form of childhood cancer – acute lymphoblastic leukemia – are often baffled at how sometimes the cancer cells survive their best efforts and the most powerful modern ...

Recommended for you

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

January 15, 2018
Prostate tumors tend to be what scientists call "indolent" - so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, ...

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.